4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-042166
President and CEO sold 147,000 shares at $12.00 ($1,764,000)
- President and CEO acquired 105,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Grossman Adam S · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +105,000 | $5.40 | $567,000 | 2,217,777 | D |
| 2026-11-05 | Sale : show line 2 in the form 10b5-1 | −105,000 | $12.00 | $1,260,000 | 2,112,777 | D |
| 2026-11-05 | Sale : show line 3 in the form 10b5-1 | −42,000 | $12.00 | $504,000 | 2,070,777 | D |
| Open-market sales · 147,000 sh · avg $12.00 · $1,764,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-05 | Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) | −105,000 | 585,950 | D |
Loading xslF345X06/form4.xml…